Annexin A3 (ANXA3) as Protein-Based Marker for Non-Invasive Molecular Diagnostics of Prostate Carcinoma

Clinical trial NCT00400894 · UNKNOWN

Trial details

NCT number: NCT00400894
Sponsor: ProteoSys AG
Status: UNKNOWN
Study type: OBSERVATIONAL

Prostate Cancer Benign Prostatic Hyperplasia Prostatic Intraepithelial Neoplasia

Start date: 2005-09-01
Enrollment: 750

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.